Organigram agrees to acquire Aurora in a C$561 million cannabis deal
On November 3, 2026, Organigram Global agreed to acquire all outstanding Aurora Cannabis shares for C$7.80 each, payable in cash, Organigram shares, or a combination subject to proration. The transaction carries an approximately C$561 million fully diluted equity value, and the price is 93% above Aurora’s August 10, 2026 unaffected close and 21% above Curaleaf’s rejected bid. Both boards support the arrangement, which remains subject to required approvals and is expected to close in January 2027.

